Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis

NCT01455220 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT01455220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01455220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis
Lead sponsor
University of South Florida
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2011
Completion date
October 31, 2014
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis